Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Krystal Biotech, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
KRYS
Nasdaq
2836
www.krystalbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Krystal Biotech, Inc.
Why Is Krystal Biotech (KRYS) Down 3.5% Since Last Earnings Report?
- Jun 5th, 2025 9:30 am
Exploring Three High Growth Tech Stocks In The US Market
- Jun 5th, 2025 5:38 am
Krystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare Conference
- Jun 3rd, 2025 6:00 am
Three Insider-Favored Growth Companies To Watch
- Jun 2nd, 2025 11:35 am
Implied Volatility Surging for Krystal Biotech Stock Options
- Jun 2nd, 2025 9:04 am
Krystal Biotech's (NASDAQ:KRYS) Solid Earnings Have Been Accounted For Conservatively
- May 13th, 2025 5:04 am
Biotech Alert: Searches spiking for these stocks today
- May 10th, 2025 9:55 am
Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain
- May 9th, 2025 8:30 am
Krystal Biotech to Present at BofA Securities 2025 Health Care Conference
- May 7th, 2025 6:00 am
Krystal Biotech First Quarter 2025 Earnings: Misses Expectations
- May 7th, 2025 4:18 am
Krystal Biotech Inc (KRYS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
- May 7th, 2025 1:08 am
Krystal Biotech Q1 Earnings and Sales Miss Estimates, Stock Down
- May 6th, 2025 11:37 am
Krystal Biotech, Inc. (KRYS) Misses Q1 Earnings and Revenue Estimates
- May 6th, 2025 7:15 am
Krystal Biotech Announces First Quarter 2025 Financial and Operating Results
- May 6th, 2025 6:00 am
Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline
- May 1st, 2025 8:01 am
Krystal Biotech, Inc. (KRYS) Earnings Expected to Grow: Should You Buy?
- Apr 29th, 2025 8:01 am
Abeona cell therapy approved by FDA for rare skin condition
- Apr 29th, 2025 4:24 am
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
- Apr 28th, 2025 5:00 am
Krystal Biotech to Present at Upcoming Scientific Conferences
- Apr 24th, 2025 6:00 am
Top Growth Companies With High Insider Ownership In April 2025
- Apr 21st, 2025 11:36 am
Scroll